Z-Medica Corp. signed an exclusive deal with Romed for sales and distribution of its QuikClot line of hemostatic agents in Belgium.

The contract is the Wallingford, Conn.-based medical device maker’s third international distribution agreement and second in the European Union. In addition to Belgium, Romed operates in Luxemburg and the Netherlands, where it’s based.

Z-Medica Corp. signed an exclusive distribution deal with the Helsinki, Finland-based medical device distributor Fenno Medical Oy.

The Wallingford, Conn.-based hemostatic agent maker said the exclusive deal includes its QuikClot-based products combat gauze, emergency dressing, interventional hemostatic bandage and trauma pad.

Combat gauze, a QuikClot-impregnated wound dressing, is the only product used by all U.S. military forces for treating hemorrhages, according to the company.

Z-Medica Corp. signed an exclusive distribution deal with Japanese electronic patient monitoring device maker Nihon-Kohden.

The contract is the Wallingford, Conn.-based medical device maker’s first international distribution agreement and grants Nihon-Kohden the exclusive right to distribute Z-Medica’s QuikClot line of hemostatic agents throughout Japan.

Z-Medica Corp. pledged to donate $25,000 to the Ohio alma mater of its co-founder to help veterans defray the cost of tuition.

The Wallingford, Conn.-based medical device maker established the "QuikClot Grant," named for its blood-clotting agent, in support of Marietta College’s Yellow Ribbon Program, which gives veterans the chance to attend the college on full scholarships. The program covers costs that aren’t paid for by GI Bill benefits.